10:01 AM EST - NeonMind Biosciences Inc. : Announced today it is setting up to offer low dose intravenous ketamine therapy for mood and anxiety disorders (IV-Ket) as an initial treatment at its recently announced, inaugural specialty mental health clinic location in Mississauga, Ontario, pending clinic licensing. NeonMind Biosciences Inc.
shares C.NEON are trading unchanged at $0.06.
